about
Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with ThiazolidinedionesLipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes.Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects.Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants.Shared Genetic Factors Involved in Celiac Disease, Type 2 Diabetes and Anorexia Nervosa Suggest Common Molecular Pathways for Chronic DiseasesMicrovesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects.Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.Innovative biomarkers for predicting type 2 diabetes mellitus: relevance to dietary management of frailty in older adults.Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease.Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients?Bio-maleimide-stained plasma microparticles can be purified in a native state and target human proximal tubular HK2 cells.A Novel Index Using Soluble CD36 Is Associated with the Prevalence of Type 2 Diabetes Mellitus: Comparison Study with Triglyceride-Glucose Index.Dynamics of circulating microparticles in obesity after weight loss.Applicability of extracellular vesicles in clinical studies.Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.Strategies for enumeration of circulating microvesicles on a conventional flow cytometer: Counting beads and scatter parameters.Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.Assessment of potential biomarkers of atherosclerosis in Indian patients with type 2 diabetes mellitus.
P2860
Q26745533-5587099A-371D-44F0-894F-E234202CCA83Q33569937-5EB0FA22-F33D-4C29-AD02-2808BFBEEC6FQ33576005-9E142BE7-BD0F-4BB1-88CA-6C3A13DD9F68Q35981964-45ACD2E9-6930-4F7E-BE8E-09DA3FE2F8E1Q36092441-FED02864-2D5F-4E4F-AA2B-CF954A3B5865Q36745194-4FFE6FA0-4882-48CC-BC74-1D7F3548E36BQ36824744-781452DE-7F25-4194-8BB5-1C08464633A7Q37619113-3BEB6922-2820-4FF0-86F7-A735D116FEE1Q38742179-D6702839-8B86-43FF-80EB-21930682DFB0Q39646058-37C5B96B-1BC1-4C93-9153-C913093A6371Q41008794-0AA0E99E-4ACA-4260-A406-43E6B82F471DQ41893820-4CFCA101-33D3-4C7B-9DB2-2C59D37F577BQ42366431-FE8DDAC5-090E-4D68-A229-5556509ADDE6Q47328598-9DD000A2-2F2B-48E4-8AE0-3BFA91538DACQ48280242-64EA8D3A-0425-47DF-9DC7-E09E40FEB668Q49807920-FF71AE6C-4544-46E1-809C-D3EC7BB2C239Q52381458-BAC88FB1-D14F-4CEF-8CED-D8737A297172Q53758887-724EAA52-73B0-471D-AB8D-F5AC8E09212BQ55317155-5479AE88-0839-4038-91DE-82114438104E
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The origin of circulating CD36 in type 2 diabetes.
@ast
The origin of circulating CD36 in type 2 diabetes.
@en
type
label
The origin of circulating CD36 in type 2 diabetes.
@ast
The origin of circulating CD36 in type 2 diabetes.
@en
prefLabel
The origin of circulating CD36 in type 2 diabetes.
@ast
The origin of circulating CD36 in type 2 diabetes.
@en
P2093
P2860
P356
P1433
P1476
The origin of circulating CD36 in type 2 diabetes
@en
P2093
A K Enjeti
M J Alkhatatbeh
R F Thorne
P2860
P2888
P356
10.1038/NUTD.2013.1
P577
2013-02-04T00:00:00Z